Skip to main content
. 2022 Jun 15;2022:8752375. doi: 10.1155/2022/8752375

Table 3.

Imaging examinations of patients with gastroenteropancreatic neuroendocrine tumors.

Imaging examination Usage (%) Positive rate (%)
CT 68.5 58/74 (78.4)
B-ultrasonics 30.6 20/33 (60.6)
MRI 19.4 20/21 (95.2)
Endoscope 47.2 51/51 (100)
PET/CT 2.8 2/3 (66.7)
SPECT 0.9 1/1 (100%)